SRS11-92
规格
Cas Number | 1467047-25-1 |
规格或纯度 | ≥98% |
纯度 | ≥98% |
包装 | 100mg 或 50mg 或 10mg 或 5mg 或 25mg 或 200mg |
产品信息
品牌 | 阿拉丁 |
溶解性 | Solubility (25°C) In vitro DMSO: 70 mg/mL (198.59 mM); Ethanol: 70 mg/mL (198.59 mM); Water: Insoluble; |
简短描述 | 铁死亡抑制剂 |
英文简短描述 | Ferroptosis Inhibitors |
过滤标签 | Apoptosis,Ferroptosis |
储存温度 | 避光,-20°C储存 |
运输条件 | 超低温冰袋运输 |
生化和生理学机理 | SRS11-92 (AA9) 是一种铁前列素-1(Fer-1)类似物,是一种强效的铁变态反应抑制剂。SRS11-92 可抑制 Erastin 在 HT-1080 人纤维肉瘤细胞中诱导的铁突变细胞死亡,EC50 为 6 nM。 |
描述 |
SRS11-92 是一种铁死亡抑制剂和 Ferrostatin-1 的衍生物。它抑制 Erastin 诱导的 HT-1080 人纤维肉瘤细胞铁致细胞死亡,EC50为6 nM。 |
英文描述 |
Information SRS11-92 SRS11-92 (AA9), a Ferrostatin-1 (Fer-1) analogue, is a potent inhibitor of ferroptosis . SRS11-92 inhibits ferroptotic cell death induced by Erastin in HT-1080 human fibrosarcoma cells with EC50 of 6 nM. Targets HT-1080 ferroptotic cell death (Cell-based assay) 6 nM(EC50) In vitro SRS11-92 is efficacious in protecting human and mouse cellular models of FRDA treated with ferric ammonium citrate (FAC) and an inhibitor of glutathione synthesis (BSO). SRS11-92 decreases the cell death associated with frataxin knockdown in healthy human fibroblasts. Cell Research(from reference) Cell lines:murine I154F FRDA fibroblasts Concentrations:50 μM to 500 nM Incubation Time:48 h |